Kardigan Files for IPO to Fund Cardiovascular Disease Treatment
✨ AI Summary
🔊 جاري الاستماع
Kardigan Inc. filed for a US initial public offering that will help fund three late-stage drugs that target the root cause of cardiovascular diseases.
